(Q37271947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Human papillomavirus infection and the primary and secondary prevention of cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

human papillomavirus infection

14 January 2020

main subject

1 reference

inferred from title

cervix uterine cancer

1 reference

5

Mark Schiffman

1 reference

19 August 2017

3

Allan Hildesheim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

Diane Solomon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Douglas R Lowy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

John T Schiller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Mark Schiffman

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

7 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1980-1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Biomarkers in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Number of cervical biopsies and sensitivity of colposcopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

Interobserver agreement in the evaluation of digitized cervical images

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri

21 January 2018

1 reference

12 December 2020

Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies

1 reference

12 December 2020

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

12 December 2020

Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type.

1 reference

12 December 2020

Risk factors for anogenital human papillomavirus infection in men.

1 reference

12 December 2020

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

1 reference

12 December 2020

Assisted primary screening using the automated ThinPrep Imaging System

1 reference

12 December 2020

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

1 reference

12 December 2020

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

12 December 2020

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

1 reference

12 December 2020

Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.

1 reference

12 December 2020

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

1 reference

12 December 2020

Global control of hepatitis B virus infection.

1 reference

12 December 2020

HPV and cervical cancer: screening or vaccination?

1 reference

12 December 2020

The global health burden of infection-associated cancers in the year 2002

1 reference

12 December 2020

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

12 December 2020

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

1 reference

12 December 2020

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

12 December 2020

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

1 reference

12 December 2020

The epidemiology of human papillomavirus infections

1 reference

12 December 2020

Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.

1 reference

12 December 2020

The molecular genetics of cervical carcinoma

1 reference

12 December 2020

Chapter 6: Immunosuppression and co-infection with HIV.

1 reference

12 December 2020

Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial

1 reference

12 December 2020

Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.

1 reference

12 December 2020

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

12 December 2020

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

1 reference

12 December 2020

Neutralizing antiviral B cell responses

1 reference

12 December 2020

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

12 December 2020

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

12 December 2020

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

1 reference

12 December 2020

Chapter 14: Role of triage testing in cervical cancer screening.

1 reference

12 December 2020

The carcinogenicity of human papillomavirus types reflects viral evolution.

1 reference

12 December 2020

Papillomavirus E6 and E7 proteins and their cellular targets

1 reference

12 December 2020

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

12 December 2020

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine

1 reference

12 December 2020

Classification of papillomaviruses

1 reference

12 December 2020

Cost-effectiveness of cervical-cancer screening in five developing countries

1 reference

12 December 2020

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

12 December 2020

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

12 December 2020

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

12 December 2020

HPV testing for primary cervical cancer screening

1 reference

12 December 2020

Human papillomavirus and cervical cancer

1 reference

12 December 2020

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies

1 reference

12 December 2020

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

12 December 2020

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

12 December 2020

Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm

1 reference

12 December 2020

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

1 reference

12 December 2020

HPV testing and visual inspection for cervical cancer screening in resource-poor regions

1 reference

12 December 2020

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

1 reference

12 December 2020

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

12 December 2020

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance

1 reference

12 December 2020

Mechanisms of human papillomavirus-induced oncogenesis.

1 reference

12 December 2020

HPV-mediated cervical carcinogenesis: concepts and clinical implications

1 reference

12 December 2020

Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy

1 reference

12 December 2020

The promise of global cervical-cancer prevention

1 reference

12 December 2020

Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind

1 reference

12 December 2020

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

12 December 2020

Effect of cough technique and cryogen gas on temperatures achieved during simulated cryotherapy

1 reference

12 December 2020

Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review

1 reference

12 December 2020

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies

1 reference

12 December 2020

Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever

1 reference

12 December 2020

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

1 reference

12 December 2020

Colposcopy at a crossroads.

1 reference

12 December 2020

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

12 December 2020

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

12 December 2020

Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stu

1 reference

12 December 2020

Risk assessment to guide the prevention of cervical cancer

1 reference

12 December 2020

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

1 reference

12 December 2020

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

1 reference

12 December 2020

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

1 reference

12 December 2020

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

12 December 2020

Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.

1 reference

12 December 2020

Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis

1 reference

12 December 2020

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

1 reference

12 December 2020

On natural and artificial vaccinations

1 reference

12 December 2020

Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS).

1 reference

12 December 2020

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

1 reference

12 December 2020

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

12 December 2020

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

1 reference

12 December 2020

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

1 reference

12 December 2020

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

1 reference

12 December 2020

Condom use and the risk of genital human papillomavirus infection in young women

1 reference

12 December 2020

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

1 reference

12 December 2020

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

1 reference

12 December 2020

Prophylactic human papillomavirus vaccines

1 reference

12 December 2020

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

1 reference

12 December 2020

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

12 December 2020

Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002

1 reference

12 December 2020

Chapter 17: Second generation HPV vaccines to prevent cervical cancer

1 reference

12 December 2020

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

1 reference

12 December 2020

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

1 reference

12 December 2020

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

7 January 2021

inferred from DOI database lookup

Assisted Primary Screening Using the Automated ThinPrep Imaging System

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23704

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.23704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798536%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference